These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6136061)

  • 1. Possible cholinergic-dopaminergic link in memory facilitation induced by oxotremorine in mice.
    Baratti CM; Introini IB; Huygens P; Gusovsky F
    Psychopharmacology (Berl); 1983; 80(2):161-5. PubMed ID: 6136061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain catecholamines modifications. The effects on memory facilitation induced by oxotremorine in mice.
    Huygens P; Baratti CM; Gardella JL; Filinger E
    Psychopharmacology (Berl); 1980; 69(3):291-4. PubMed ID: 6774370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory-modulatory effects of centrally acting noradrenergic drugs: possible involvement of brain cholinergic mechanisms.
    Introini-Collison IB; Baratti CM
    Behav Neural Biol; 1992 May; 57(3):248-55. PubMed ID: 1319706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice.
    Baratti CM; Huygens P; Miño J; Merlo A; Gardella J
    Psychopharmacology (Berl); 1979 Jun; 64(1):85-8. PubMed ID: 113837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective brain noradrenaline depletion induced by the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) does not prevent the memory facilitation induced by a muscarinic agonist in mice.
    Introini IB; Baratti CM; Huygens P
    Psychopharmacology (Berl); 1984; 82(1-2):107-12. PubMed ID: 6420819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amygdala beta-noradrenergic influences on memory storage involve cholinergic activation.
    Introini-Collison IB; Dalmaz C; McGaugh JL
    Neurobiol Learn Mem; 1996 Jan; 65(1):57-64. PubMed ID: 8673407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the post-training cholinergic tone antagonizes the impairment of retention induced by a nitric oxide synthase inhibitor in mice.
    Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1996 May; 65(3):207-12. PubMed ID: 8616584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidation in mice.
    Baratti CM; Introini IB; Huygens P
    Behav Neural Biol; 1984 Mar; 40(2):155-69. PubMed ID: 6732709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible peripheral adrenergic and central dopaminergic influences in memory consolidation.
    Gozzani JL; Izquierdo I
    Psychopharmacology (Berl); 1976 Aug; 49(1):109-11. PubMed ID: 822441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval.
    Altman HJ; Stone WS; Ogren SO
    Behav Neural Biol; 1987 Jul; 48(1):49-62. PubMed ID: 3632552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impairment of retention induced by beta-endorphin in mice may be mediated by a reduction of central cholinergic activity.
    Introini IB; Baratti CM
    Behav Neural Biol; 1984 Jul; 41(2):152-63. PubMed ID: 6148931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cholinergic-dopaminergic systems in the regulation of memory storage in aversively motivated learning tasks.
    Gasbarri A; Introini-Collison IB; Packard MG; Pacitti C; McGaugh JL
    Brain Res; 1993 Nov; 627(1):72-8. PubMed ID: 8293306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central pharmacological control of corticosterone secretion in the intact rat. Demonstration of cholinergic and serotoninergic facilitatory and alpha-adrenergic inhibitory mechanisms.
    Steiner JA; Grahame-Smith DG
    Psychopharmacology (Berl); 1980; 71(3):213-7. PubMed ID: 6256794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory facilitation by naloxone is due to release of dopaminergic and beta-adrenergic systems from tonic inhibition.
    Izquierdo I; Graudenz M
    Psychopharmacology (Berl); 1980; 67(3):265-8. PubMed ID: 6247739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system.
    Li Z; Wu CF; Pei G; Xu NJ
    Pharmacol Biochem Behav; 2001 Mar; 68(3):507-13. PubMed ID: 11325406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oxotremorine on inhibitory avoidance behaviour in two inbred strains of mice: interaction with 5-methoxy-NN-dimethyltriptamine.
    Pavone F; Fagioli S; Castellano C
    Psychopharmacology (Berl); 1993; 112(2-3):249-52. PubMed ID: 7871027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The post-training memory enhancement induced by physostigmine and oxotremorine in mice is not state-dependent.
    Baratti CM; Kopf SR
    Neurobiol Learn Mem; 1996 Mar; 65(2):121-4. PubMed ID: 8833101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid peptidergic systems modulate the activity of beta-adrenergic mechanisms during memory consolidation processes.
    Introini-Collison IB; Baratti CM
    Behav Neural Biol; 1986 Sep; 46(2):227-41. PubMed ID: 3021111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnesia induced by short-term treatment with ethanol: attenuation by pretest oxotremorine.
    Brioni JD; McGaugh JL; Izquierdo I
    Pharmacol Biochem Behav; 1989 May; 33(1):27-9. PubMed ID: 2780785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic stress and memory: implication of the central cholinergic system.
    Zerbib R; Laborit H
    Pharmacol Biochem Behav; 1990 Aug; 36(4):897-900. PubMed ID: 2217520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.